194 related articles for article (PubMed ID: 33789422)
41. Allicin-inspired pyridyl disulfides as antimicrobial agents for multidrug-resistant Staphylococcus aureus.
Sheppard JG; McAleer JP; Saralkar P; Geldenhuys WJ; Long TE
Eur J Med Chem; 2018 Jan; 143():1185-1195. PubMed ID: 29126733
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and Bioactivities of New Membrane-Active Agents with Aromatic Linker: High Selectivity and Broad-Spectrum Antibacterial Activity.
Chu W; Yang Y; Cai J; Kong H; Bai M; Fu X; Qin S; Zhang E
ACS Infect Dis; 2019 Sep; 5(9):1535-1545. PubMed ID: 31328496
[TBL] [Abstract][Full Text] [Related]
43. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
Dombach JL; Quintana JLJ; Detweiler CS
mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
[TBL] [Abstract][Full Text] [Related]
44. Amphiphilic cationic β(3R3)-peptides: membrane active peptidomimetics and their potential as antimicrobial agents.
Mosca S; Keller J; Azzouz N; Wagner S; Titz A; Seeberger PH; Brezesinski G; Hartmann L
Biomacromolecules; 2014 May; 15(5):1687-95. PubMed ID: 24694059
[TBL] [Abstract][Full Text] [Related]
45. Recent Advances in Amphipathic Peptidomimetics as Antimicrobial Agents to Combat Drug Resistance.
Su M; Su Y
Molecules; 2024 May; 29(11):. PubMed ID: 38893366
[TBL] [Abstract][Full Text] [Related]
46. Development of Bis-cyclic Imidazolidine-4-one Derivatives as Potent Antibacterial Agents.
Wang M; Gao R; Zheng M; Sang P; Li C; Zhang E; Li Q; Cai J
J Med Chem; 2020 Dec; 63(24):15591-15602. PubMed ID: 32914977
[TBL] [Abstract][Full Text] [Related]
47. Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life.
Bhosle GS; Nawale L; Yeware AM; Sarkar D; Fernandes M
Eur J Med Chem; 2018 May; 152():358-369. PubMed ID: 29738954
[TBL] [Abstract][Full Text] [Related]
48. Helical Antimicrobial Sulfono-γ-AApeptides.
Li Y; Wu H; Teng P; Bai G; Lin X; Zuo X; Cao C; Cai J
J Med Chem; 2015 Jun; 58(11):4802-11. PubMed ID: 26020456
[TBL] [Abstract][Full Text] [Related]
49. Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.
Murugan RN; Jacob B; Kim EH; Ahn M; Sohn H; Seo JH; Cheong C; Hyun JK; Lee KS; Shin SY; Bang JK
Bioorg Med Chem Lett; 2013 Aug; 23(16):4633-6. PubMed ID: 23816372
[TBL] [Abstract][Full Text] [Related]
50. N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Opoku-Temeng C; Naclerio GA; Mohammad H; Dayal N; Abutaleb NS; Seleem MN; Sintim HO
Eur J Med Chem; 2018 Jul; 155():797-805. PubMed ID: 29957525
[TBL] [Abstract][Full Text] [Related]
51. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model.
Tague AJ; Putsathit P; Hutton ML; Hammer KA; Wales SM; Knight DR; Riley TV; Lyras D; Keller PA; Pyne SG
Eur J Med Chem; 2019 May; 170():203-224. PubMed ID: 30901686
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
[TBL] [Abstract][Full Text] [Related]
53.
Lin S; Wade JD; Liu S
Acc Chem Res; 2021 Jan; 54(1):104-119. PubMed ID: 33346639
[TBL] [Abstract][Full Text] [Related]
54. In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria.
Lin S; Li H; Tao Y; Liu J; Yuan W; Chen Y; Liu Y; Liu S
J Med Chem; 2020 Jun; 63(11):5797-5815. PubMed ID: 32400157
[TBL] [Abstract][Full Text] [Related]
55. Development of Membrane-Active Honokiol/Magnolol Amphiphiles as Potent Antibacterial Agents against Methicillin-Resistant
Guo Y; Hou E; Wen T; Yan X; Han M; Bai LP; Fu X; Liu J; Qin S
J Med Chem; 2021 Sep; 64(17):12903-12916. PubMed ID: 34432450
[TBL] [Abstract][Full Text] [Related]
56. Amphipathic sulfonamidobenzamides mimicking small antimicrobial marine natural products; investigation of antibacterial and anti-biofilm activity against antibiotic resistant clinical isolates.
Igumnova EM; Mishchenko E; Haug T; Blencke HM; Sollid JUE; Fredheim EGA; Lauksund S; Stensvåg K; Strøm MB
Bioorg Med Chem; 2018 Sep; 26(17):4930-4941. PubMed ID: 30185388
[TBL] [Abstract][Full Text] [Related]
57. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.
Riahifard N; Mozaffari S; Aldakhil T; Nunez F; Alshammari Q; Alshammari S; Yamaki J; Parang K; Tiwari RK
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360400
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).
Mohammad H; Reddy PV; Monteleone D; Mayhoub AS; Cushman M; Seleem MN
Eur J Med Chem; 2015 Apr; 94():306-16. PubMed ID: 25771109
[TBL] [Abstract][Full Text] [Related]
59. Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones.
Jahnsen RD; Frimodt-Møller N; Franzyk H
J Med Chem; 2012 Aug; 55(16):7253-61. PubMed ID: 22809409
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
